362
Views
5
CrossRef citations to date
0
Altmetric
Original

The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy

, MD, PhD, , , , , , , , & show all
Pages 287-299 | Received 05 Jan 2006, Accepted 09 Mar 2006, Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Leila Sharif-Khatibi, Amina Kariminia, Sameide Khoei & Bahram Goliaei. (2007) Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells. International Journal of Hyperthermia 23:8, pages 645-655.
Read now

Articles from other publishers (4)

Shin-ichiro Masunaga, Yu Sanada, Keizo Tano, Yoshinori Sakurai, Hiroki Tanaka, Takushi Takata, Minoru Suzuki & Koji Ono. (2020) An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness. Journal of Radiation Research 61:6, pages 876-885.
Crossref
Yuki Wada, Katsumi Hirose, Takaomi Harada, Mariko Sato, Tsubasa Watanabe, Akira Anbai, Manabu Hashimoto & Yoshihiro Takai. (2018) Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy. Journal of Radiation Research 59:2, pages 122-128.
Crossref
Hiroyuki OhshimaHitoshi Hori & Hiroshi Terada. 2016. Encyclopedia of Biocolloid and Biointerface Science 2V Set. Encyclopedia of Biocolloid and Biointerface Science 2V Set 255 259 .
Hideko Nagasawa, Yoshihiro Uto, Kenneth Lee Kirk & Hitoshi Hori. (2006) Design of Hypoxia-Targeting Drugs as New Cancer Chemotherapeutics. Biological and Pharmaceutical Bulletin 29:12, pages 2335-2342.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.